Skip to Main content Skip to Navigation
Journal articles

Current trends with FOXP3 + regulatory T cell immunotherapy to contest autoimmunity and inflammation

Jamma Trinath 1 Jagadeesh Bayry 2
1 Birla Institute of Technology & Science [Telangana]
2 CRC - Inserm U1138 - Immunopathologie et immunointervention thérapeutique
CRC (UMR_S_1138 / U1138) - Centre de Recherche des Cordeliers
Keywords : Treg Tregs autoimmune diseases chronic inflammatory diseases therapy tolerance
Document type :
Journal articles
Complete list of metadata
https://www.hal.inserm.fr/inserm-02455416
Contributor : Jagadeesh Bayry Connect in order to contact the contributor
Submitted on : Sunday, January 26, 2020 - 10:31:50 AM
Last modification on : Monday, December 14, 2020 - 9:41:28 AM

Links full text

openaccess

Identifiers

Collections

INSERM | UNIV-PARIS5 | SORBONNE-UNIVERSITE | UNIV-PARIS7 | CORDELIERS | EPHE | USPC | SU-SCIENCES | UNIV-PARIS | UP-SANTE | PSL | SU-TI

Citation

Jamma Trinath, Jagadeesh Bayry. Current trends with FOXP3 + regulatory T cell immunotherapy to contest autoimmunity and inflammation. Immunotherapy, Future Medicine, 2019, 11 (9), pp.755-758. ⟨10.2217/imt-2019-0069⟩. ⟨inserm-02455416⟩

Export

BibTeX TEI DC DCterms EndNote

Share

Metrics

Record views

440